Posttransplantation immunosuppression usually consists of induction therapy (antithymocyte globulin [ATG] and / or IL-2 receptor blocker), followed by triple maintenance immunosuppression with a corticosteroid, an antiproliferative drug (eg, basiliximab), and a calcineurin inhibitor (see table Immunosuppressants Used to Treat Transplant Rejection).